Design Therapeutics, Inc. (DSGN)

NASDAQ: DSGN · IEX Real-Time Price · USD

3.760

+0.110 (3.01%)

At close: Apr 25, 2024, 4:00 PM

3.780

+0.020 (0.53%)

After-hours: Apr 25, 2024, 5:59 PM EDT

Design Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	21.2	26.5	298.57	2.38	0.08
Short-Term Investments	260.6	303.89	85.5	33.71	0
Cash & Cash Equivalents	281.8	330.39	384.06	36.09	0.08
Cash Growth	-14.71%	-13.98%	964.15%	46771.43%	-
Other Current Assets	2.79	4.73	1.37	0.14	0.01
Total Current Assets	284.58	335.12	385.44	36.23	0.09
Property, Plant & Equipment	4.63	5.56	5.12	0.07	0
Other Long-Term Assets	0.43	0.46	0	0.21	0
Total Long-Term Assets	5.06	6.02	5.12	0.28	0
Total Assets	289.64	341.14	390.56	36.52	0.09
Accounts Payable	1.94	3.03	1.62	1.4	2.72
Deferred Revenue	0	0	0	0	0.2
Current Debt	0	0	0	0	0.7
Other Current Liabilities	7.68	7.75	3.66	0.93	0.11
Total Current Liabilities	9.62	10.78	5.28	2.33	3.73
Long-Term Debt	2.33	3.05	3.14	0	0
Other Long-Term Liabilities	0	0	0	0.15	0
Total Long-Term Liabilities	2.33	3.05	3.14	0.15	0
Total Liabilities	11.96	13.83	8.43	2.48	3.73
Total Debt	2.33	3.05	3.14	0	0.7
Debt Growth	-23.50%	-2.96%	-	-	-
Retained Earnings	-177.63	-110.76	-47.46	-11.92	-3.64
Comprehensive Income	0.06	-3.36	-0.24	0.16	0
Shareholders' Equity	277.69	327.31	382.13	-11.32	-3.64
Net Cash / Debt	279.46	327.34	380.92	36.09	-0.62
Net Cash / Debt Growth	-14.62%	-14.07%	955.44%	-	-
Net Cash Per Share	4.99	5.88	8.29	2.28	-0.04
Working Capital	274.96	324.34	380.15	33.9	-3.64
Book Value Per Share	4.96	5.88	8.32	-0.72	-0.23

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).